• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶2:新冠病毒的分子通道

ACE2: the molecular doorway to SARS-CoV-2.

作者信息

Medina-Enríquez Miriam Marlene, Lopez-León Sandra, Carlos-Escalante José Alberto, Aponte-Torres Zuleika, Cuapio Angelica, Wegman-Ostrosky Talia

机构信息

Facultad de Farmacia, Universidad de Barcelona, Barcelona, Spain.

Global Drug Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.

出版信息

Cell Biosci. 2020 Dec 30;10(1):148. doi: 10.1186/s13578-020-00519-8.

DOI:10.1186/s13578-020-00519-8
PMID:33380340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7772801/
Abstract

The angiotensin-converting enzyme 2 (ACE2) is the host functional receptor for the new virus SARS-CoV-2 causing Coronavirus Disease 2019. ACE2 is expressed in 72 different cell types. Some factors that can affect the expression of the ACE2 are: sex, environment, comorbidities, medications (e.g. anti-hypertensives) and its interaction with other genes of the renin-angiotensin system and other pathways. Different factors can affect the risk of infection of SARS-CoV-2 and determine the severity of the symptoms. The ACE2 enzyme is a negative regulator of RAS expressed in various organ systems. It is with immunity, inflammation, increased coagulopathy, and cardiovascular disease. In this review, we describe the genetic and molecular functions of the ACE2 receptor and its relation with the physiological and pathological conditions to better understand how this receptor is involved in the pathogenesis of COVID-19. In addition, it reviews the different comorbidities that interact with SARS-CoV-2 in which also ACE2 plays an important role. It also describes the different factors that interact with the virus that have an influence in the expression and functional activities of the receptor. The goal is to provide the reader with an understanding of the complexity and importance of this receptor.

摘要

血管紧张素转换酶2(ACE2)是引发2019冠状病毒病的新型病毒SARS-CoV-2的宿主功能性受体。ACE2在72种不同的细胞类型中表达。一些可影响ACE2表达的因素包括:性别、环境、合并症、药物(如抗高血压药)及其与肾素-血管紧张素系统的其他基因和其他途径的相互作用。不同因素可影响SARS-CoV-2的感染风险并决定症状的严重程度。ACE2酶是在各种器官系统中表达的肾素-血管紧张素系统的负调节因子。它与免疫、炎症、凝血障碍增加和心血管疾病有关。在本综述中,我们描述了ACE2受体的遗传和分子功能及其与生理和病理状况的关系,以更好地了解该受体如何参与COVID-19的发病机制。此外,还综述了与SARS-CoV-2相互作用且ACE2也在其中发挥重要作用的不同合并症。还描述了与病毒相互作用且对受体的表达和功能活性有影响的不同因素。目的是让读者了解该受体的复杂性和重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/c326ae1a25d3/13578_2020_519_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/37714d649a87/13578_2020_519_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/5cc6ac024712/13578_2020_519_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/0d75f5b61dbf/13578_2020_519_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/fd2db5b7d982/13578_2020_519_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/c326ae1a25d3/13578_2020_519_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/37714d649a87/13578_2020_519_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/5cc6ac024712/13578_2020_519_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/0d75f5b61dbf/13578_2020_519_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/fd2db5b7d982/13578_2020_519_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d460/7772920/c326ae1a25d3/13578_2020_519_Fig5_HTML.jpg

相似文献

1
ACE2: the molecular doorway to SARS-CoV-2.血管紧张素转换酶2:新冠病毒的分子通道
Cell Biosci. 2020 Dec 30;10(1):148. doi: 10.1186/s13578-020-00519-8.
2
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
3
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator.血管紧张素转换酶2(ACE2):严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体和肾素-血管紧张素系统(RAS)调节剂
Acta Pharm Sin B. 2021 Jan;11(1):1-12. doi: 10.1016/j.apsb.2020.10.006. Epub 2020 Oct 13.
4
Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.下调膜结合血管紧张素转换酶 2(ACE2)受体在 COVID-19 免疫病理中起关键作用。
Curr Drug Targets. 2021;22(3):254-281. doi: 10.2174/1389450121666201020154033.
5
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.SARS-CoV-2 利用血管紧张素转换酶 2 进入细胞进行复制的机制概述:与肾素-血管紧张素系统相关的可能治疗选择。
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):317-325. doi: 10.1093/ehjcvp/pvaa053.
6
Characterization of the angiotensin-converting enzyme 2 (ACE2), the main receptor for the SARS-CoV-2 virus.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的主要受体——血管紧张素转换酶2(ACE2)的特征
Am J Clin Exp Immunol. 2023 Jun 15;12(3):24-44. eCollection 2023.
7
Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.血管紧张素转换酶 2(ACE2)在 COVID-19 所致急性呼吸窘迫综合征发病机制中的作用。
Front Immunol. 2021 Dec 22;12:732690. doi: 10.3389/fimmu.2021.732690. eCollection 2021.
8
ACE2: from protection of liver disease to propagation of COVID-19.ACE2:从保护肝脏疾病到传播 COVID-19。
Clin Sci (Lond). 2020 Dec 11;134(23):3137-3158. doi: 10.1042/CS20201268.
9
Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?血管紧张素转换酶 2 的调节:预防 COVID-19 的潜在靶点?
Front Endocrinol (Lausanne). 2021 Oct 22;12:725967. doi: 10.3389/fendo.2021.725967. eCollection 2021.
10
Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.呼吸系统疾病背景下的血管紧张素转换酶2(ACE2)及其在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的重要性
Pharmaceuticals (Basel). 2021 Aug 17;14(8):805. doi: 10.3390/ph14080805.

引用本文的文献

1
Do Long COVID and COVID Vaccine Side Effects Share Pathophysiological Picture and Biochemical Pathways?长期新冠症状和新冠疫苗副作用是否具有共同的病理生理特征和生化途径?
Int J Mol Sci. 2025 Aug 15;26(16):7879. doi: 10.3390/ijms26167879.
2
Profiling of proteases involved in SARS-CoV-2 pathogenesis in human saliva: Influence of age and gender.新冠病毒致病过程中人类唾液中蛋白酶的分析:年龄和性别的影响
J Genet Eng Biotechnol. 2025 Sep;23(3):100509. doi: 10.1016/j.jgeb.2025.100509. Epub 2025 Jun 17.
3
Impact of Obesity and Ageing on the Expression of Key Mediators of SARS-CoV-2 Infection in Human Adipose Tissue.

本文引用的文献

1
Molecular docking reveals the potential of flavonoids to inhibit COVID-19 virus main protease.分子对接揭示了黄酮类化合物抑制新冠病毒主要蛋白酶的潜力。
RSC Adv. 2020 May 21;10(33):19570-19575. doi: 10.1039/d0ra03582c. eCollection 2020 May 20.
2
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.雄激素信号调节 SARS-CoV-2 受体水平,并与男性严重 COVID-19 症状相关。
Cell Stem Cell. 2020 Dec 3;27(6):876-889.e12. doi: 10.1016/j.stem.2020.11.009. Epub 2020 Nov 17.
3
COVID-19 and diabetes mellitus: from pathophysiology to clinical management.
肥胖和衰老对人脂肪组织中SARS-CoV-2感染关键介质表达的影响。
Int J Mol Sci. 2025 Jul 29;26(15):7313. doi: 10.3390/ijms26157313.
4
Assessment of Selected Biochemical Parameters of the Renin-Angiotensin-Aldosterone System in Repeat Convalescent Plasma Donors in the Context of Long-Term Changes Following SARS-CoV-2 Infection.在新冠病毒感染后的长期变化背景下,对重复恢复期血浆捐献者肾素-血管紧张素-醛固酮系统的选定生化参数进行评估。
J Clin Med. 2025 Jul 10;14(14):4910. doi: 10.3390/jcm14144910.
5
Rapid Risk Assessment Framework to Estimate Potential for Spillback at Human-Wildlife Interfaces.用于评估人类与野生动物界面溢出可能性的快速风险评估框架。
Transbound Emerg Dis. 2025 Jun 13;2025:4334954. doi: 10.1155/tbed/4334954. eCollection 2025.
6
Genetic association of ACE2 rs2285666 (C>T) and rs2106809 (A>G) and susceptibility to SARS-CoV-2 infection among the Ghanaian population.加纳人群中ACE2基因rs2285666(C>T)和rs2106809(A>G)的基因关联与对SARS-CoV-2感染的易感性
Front Genet. 2025 May 26;16:1555515. doi: 10.3389/fgene.2025.1555515. eCollection 2025.
7
Recent Advances in Field-Effect Transistor-Based Biosensors for Label-Free Detection of SARS-CoV-2.基于场效应晶体管的SARS-CoV-2无标记检测生物传感器的最新进展
Small Sci. 2023 Dec 21;4(2):2300058. doi: 10.1002/smsc.202300058. eCollection 2024 Feb.
8
Diagnosis, Severity, and Prognosis from Potential Biomarkers of COVID-19 in Urine: A Review of Clinical and Omics Results.尿液中新冠病毒潜在生物标志物的诊断、严重程度及预后:临床与组学结果综述
Metabolites. 2024 Dec 22;14(12):724. doi: 10.3390/metabo14120724.
9
Virucidal activity of porphyrin-based metal-organic frameworks against highly pathogenic coronaviruses and hepatitis C virus.基于卟啉的金属有机框架对高致病性冠状病毒和丙型肝炎病毒的杀病毒活性
Mater Today Bio. 2024 Aug 2;28:101165. doi: 10.1016/j.mtbio.2024.101165. eCollection 2024 Oct.
10
Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy.意大利米兰 SARS-CoV-2 大流行第一波期间 COVID-19 患者循环细胞因子和趋化因子的多重微阵列分析。
BMC Immunol. 2024 Jul 26;25(1):49. doi: 10.1186/s12865-024-00641-z.
新型冠状病毒肺炎与糖尿病:从病理生理学到临床管理。
Nat Rev Endocrinol. 2021 Jan;17(1):11-30. doi: 10.1038/s41574-020-00435-4. Epub 2020 Nov 13.
4
Human recombinant soluble ACE2 in severe COVID-19.严重新型冠状病毒肺炎中的人重组可溶性血管紧张素转换酶2
Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
5
Neuropilin-1 is a host factor for SARS-CoV-2 infection.神经纤毛蛋白 1 是 SARS-CoV-2 感染的宿主因子。
Science. 2020 Nov 13;370(6518):861-865. doi: 10.1126/science.abd3072. Epub 2020 Oct 20.
6
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.神经纤毛蛋白-1 促进 SARS-CoV-2 细胞进入和感染性。
Science. 2020 Nov 13;370(6518):856-860. doi: 10.1126/science.abd2985. Epub 2020 Oct 20.
7
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.干扰素和病毒诱导新型截断 ACE2 同工型,而非全长 SARS-CoV-2 受体。
Nat Genet. 2020 Dec;52(12):1283-1293. doi: 10.1038/s41588-020-00731-9. Epub 2020 Oct 19.
8
Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease.解析 ACE2 作为 SARS-CoV-2 的结合受体在炎症性肠病中的作用。
Inflamm Bowel Dis. 2020 Nov 19;26(12):1787-1795. doi: 10.1093/ibd/izaa249.
9
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
10
Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2.血管紧张素转化酶 2:调节 SARS-CoV-2 疾病毒力的保护因素。
IUBMB Life. 2020 Dec;72(12):2533-2545. doi: 10.1002/iub.2391. Epub 2020 Oct 8.